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UL20 Protein Functions Precede and Are Required for the UL11
Functions of Herpes Simplex Virus Type 1 Cytoplasmic
Virion Envelopment䌤
Preston A. Fulmer,1 Jeffrey M. Melancon,1 Joel D. Baines,2 and Konstantin G. Kousoulas1*
Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of
Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana 70803,1 and Department of
Microbiology and Immunology, Cornell University, Ithaca, New York 148532

Egress of herpes simplex virus type 1 (HSV-1) from the nucleus of the infected cell to extracellular spaces
involves a number of distinct steps, including primary envelopment by budding into the perinuclear space,
de-envelopment into the cytoplasm, cytoplasmic reenvelopment, and translocation of enveloped virions to
extracellular spaces. UL20/gK-null viruses are blocked in cytoplasmic virion envelopment and egress, as
indicated by an accumulation of unenveloped or partially enveloped capsids in the cytoplasm. Similarly,
UL11-null mutants accumulate unenveloped capsids in the cytoplasm. To assess whether UL11 and UL20/gK
function independently or synergistically in cytoplasmic envelopment, recombinant viruses having either the
UL20 or UL11 gene deleted were generated. In addition, a recombinant virus containing a deletion of both
UL20 and UL11 genes was constructed using the HSV-1(F) genome cloned into a bacterial artificial chromosome. Ultrastructural examination of virus-infected cells showed that both UL20- and UL11-null viruses
accumulated unenveloped capsids in the cytoplasm. However, the morphology and distribution of the accumulated capsids appeared to be distinct, with the UL11-null virions forming aggregates of capsids having
diffuse tegument-derived material and the UL20-null virus producing individual capsids in close juxtaposition
to cytoplasmic membranes. The UL20/UL11 double-null virions appeared morphologically similar to the
UL20-null viruses. Experiments on the kinetics of viral replication revealed that the UL20/UL11 double-null
virus replicated in a manner similar to the UL20-null virus. Additional experiments revealed that transiently
expressed UL11 localized to the trans-Golgi network (TGN) independently of either gK or UL20. Furthermore,
virus infection with the UL11/UL20 double-null virus did not alter the TGN localization of transiently
expressed UL11 or UL20 proteins, indicating that these proteins did not interact. Taken together, these results
show that the intracellular transport and TGN localization of UL11 is independent of UL20/gK functions, and
that UL20/gK are required and function prior to UL11 protein in virion cytoplasmic envelopment.
model is supported by evidence that specific mutations within
tegument proteins and multiple membrane proteins and glycoproteins inhibit cytoplasmic envelopment (32, 34). Apparently, multiple glycoproteins may be concurrently involved in
cytoplasmic virion envelopment. The simultaneous absence of
both gM and gE or of gM and the gE cytoplasmic tail results in
inhibition of cytoplasmic envelopment for pseudorabies virus
(PRV) (5, 6); however, deletion of gM or gE does not appear
to affect HSV-1 cytoplasmic envelopment. In contrast, deletion
of both HSV-1 gD and gE causes accumulation of capsids in
the cytoplasm of infected cells, presumably due to loss of
contacts with tegument proteins (32, 34). These results suggest
that PRV and HSV-1 cytoplasmic envelopment may rely on
different repertoires of protein-protein interactions to drive
cytoplasmic virion envelopment.
Of particular interest to these investigations are the membrane proteins UL11 (2, 23, 24), UL20 (3, 14, 18, 30), and
UL53 (gK) (13, 21, 22), which are known to be important
determinants of cytoplasmic envelopment for both PRV and
HSV-1. The UL11 gene encodes a 96-amino-acid tegument
protein, which is N-terminally myristylated (28) and palmitylated (25). The UL11 protein localizes to nuclear and TGNderived membranes in infected cells (1) but only to the TGNderived membranes in noninfected cells (4). UL11 was shown

Herpes simplex virus type 1 (HSV-1) morphogenesis occurs
in multiple stages within infected cells. Initially, the virion
capsid assembles within the nucleus and the virion acquires an
initial envelope by budding into the perinuclear spaces (39).
Subsequently, these enveloped virions fuse with the outer nuclear lamellae, leading to the accumulation of unenveloped
capsids in the cytoplasm. Within the cytoplasm, a number of
additional tegument proteins attach to the capsid and the fully
tegumented capsids bud into cytoplasmic vesicles, which
mostly likely originate from the trans-Golgi network (TGN).
Enveloped virions are ultimately secreted to extracellular
spaces through the utilization of cellular vesicular trafficking
systems (7, 19, 20, 33, 40, 43). The process by which the tegumented cytoplasmic capsids bud into TGN-derived vesicles is
not well understood. The prevalent model calls for specific
interactions among viral tegument proteins and membrane
proteins and glycoproteins embedded within TGN membranes
as key factors that drive cytoplasmic virion envelopment. This
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to specifically interact with the UL16 tegument protein, providing a potential docking mechanism for tegumented capsids
onto TGN-derived membranes(26, 42). An HSV UL11-null
mutant obtained by deletion of most of the UL11-coding region accumulated capsids in the nucleus and unenveloped capsids in the cytoplasm (2), while a PRV null virus with the entire
UL11 gene deleted showed accumulation of unenveloped capsids in the cytoplasm of infected cells embedded in tegumentlike material (24).
The UL20 and UL53 (gK) genes encode multipass transmembrane proteins of 222 and 338 amino acids, respectively,
and are conserved in all alphaherpesviruses (9, 29, 38). UL20p
and gK localize to TGN membranes after endocytosis from cell
surfaces (14). UL20p and gK are essential for cytoplasmic
virion morphogenesis, since mutant viruses lacking either gK
or UL20p accumulate capsids within the cytoplasm that are
unable to acquire envelopes by budding into TGN-associated
membranes (11, 12, 14, 18, 30). Furthermore, UL20p is essential for virus-induced cell fusion caused by either gB or gK
syncytial mutations, and it is necessary for gK cell surface
expression. Recently, our laboratory has shown that gK and
UL20 interact and that this interaction is essential for their
cotransport and membrane fusion and virion morphogenesis
functions (15, 31).
The purpose of the present investigations was twofold: (i) to
revisit the role of UL11 in virion morphogenesis and egress by
constructing a new recombinant UL11-null virus in the HSV1(F) genetic background that could be directly compared to
our previously constructed gK-null and UL20-null viruses and
(ii) to investigate whether UL11 and the gK/UL20 heterodimer
functioned synergistically or independently of each other in the
late stages of cytoplasmic virion morphogenesis. The bacterial
artificial chromosome (BAC)-cloned HSV-1(F) viral genome
was used to generated UL11 single-null and UL11/UL20 double-null viruses. Characterization of the replication and ultrastructural characteristics of these recombinant viruses revealed
that UL11 played an important role in cytoplasmic virion envelopment. Furthermore, although UL11 and UL20 were independently transported and localized at the TGN, UL20
functions preceded and were required for UL11 functions in
cytoplasmic virion envelopment.
MATERIALS AND METHODS
Cells, viruses, and plasmids. African green monkey kidney (Vero) cells were
obtained from the American Type Culture Collection (Manassas, VA). Cells
were maintained in Dulbecco’s modified Eagle’s medium (Gibco-BRL, Grand
Island, NY) supplemented with 10% fetal calf serum and antibiotics. The UL19and UL20-complementing cell line G5 was a gift of P. Desai (Johns Hopkins
Medical Center) (10). A plasmid encoding UL11-green fluorescent protein
(GFP) was a gift of J. Wills (26). Construction of both a UL20-3xFLAG plasmid
and a gK-V5 plasmid was described previously (15). Cell line Fd20-1 constitutively expressing UL20 was constructed in this laboratory (30).
Construction of HSV-1 mutants with deletions of the UL11 and/or UL20 genes
(pYEbac102, pYEbac102⌬UL11, pYEbac102⌬UL20, and pYEBac102⌬UL11⌬UL20.).
Insertion-deletion mutagenesis of pYEbac102 DNA was accomplished in Escherichia coli with the  gam recE recT (GET) recombination system (36, 37) as
described previously for mutagenesis of the Kaposi’s sarcoma-associated herpesvirus genome (27). Electrocompetent YEbac102 Escherichia coli DH10B cells
were transformed with plasmid pGETrec, which contains the genes recE, recT,
and bacteriophage  gam, and grown on plates containing chloramphenicol (12.5
g/ml) and ampicillin (100 g/ml). Individual colonies were picked and grown
overnight in Luria-Bertani (LB) medium containing chloramphenicol and ampicillin. The next day, the culture was inoculated into 250 ml of LB medium
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containing chloramphenicol and ampicillin until an optical density at 600 nm of
0.4 was reached. Addition of L-arabinose to a final concentration of 0.2% (wt/vol)
and further incubation for 40 min induced expression of the recE, recT, and 
gam genes from plasmid pGETrec. The cells were then harvested and made
electrocompetent.
For the ⌬UL11-Kan mutation, a PCR fragment containing a kanamycin
resistance (Kan) gene cassette flanked by ⬃50 bp of viral sequences on both
sides was used for recombination to construct pYEbac⌬UL11, containing the
Kan gene cassette within the targeted UL11 genomic region. Specifically, the
Kan gene cassette was inserted 94 nucleotides downstream of the UL11 ATG
codon to avoid interruption of the UL12 open reading frame (ORF), which
overlaps with the 5⬘ terminus of the UL11 gene by 87 nucleotides. The
remaining coding sequence of the UL11 gene was deleted up to three nucleotides past the TAA termination codon. The construction of the ⌬UL20GFP-Zeo mutation was described previously (31). For the ⌬UL11⌬UL20
mutation, a PCR fragment containing either a Kan gene cassette or a GFPzeocin resistance cassette flanked by ⬃50 bp of viral sequences on both sides
was used for recombination to construct pYEbac102⌬UL11⌬UL20. Briefly,
40 l of electrocompetent DH10B cells harboring both pYEbac102 and
pGETrec were electroporated with 200 ng of each PCR product to delete the
target gene(s) (UL11 or UL20) with standard electroporation parameters (1.8
kV/cm, 200 ⍀, and 25 F). Following electroporation, cells were grown in 1
ml of LB medium for 60 min and subsequently streaked onto LB agar plates
containing chloramphenicol (12.5 g/ml) as well as either kanamycin (50
g/ml) or zeocin (25 g/ml). Mutant pYEbac102 DNA containing a deletion
in the UL11 or UL20 gene was isolated from bacterial colonies, and a second
round of electroporation was performed to remove plasmid pGETrec. Following electroporation, cells were grown on agar plates containing chloramphenicol as well as either kanamycin or zeocin.
Confirmation of the targeted mutations in pYEbac102 DNA. HSV-1 BAC
DNAs (pYEbac102, pYEbac102⌬UL11, and pYEbac102⌬UL11⌬UL20) were
purified from 500 ml of BAC cultures with the QIAGEN large-construct kit
(QIAGEN, Valencia, CA). PCR primers that lie outside both UL11 and UL20
were designed. A PCR test was performed to verify that the desired mutations
were present. All mutations were sequenced to verify the presence of the desired
mutations in the BACs. To verify that no spurious mutations were introduced
into the viral genome of the individual BAC mutants during mutagenesis or
during the transfection procedure, each null mutation was complemented by
expression vectors containing the appropriate gene or genes. Each complemented virus was verified to have the plaque phenotype characteristics of the
wild-type BAC YEbac102.
Transfection of HSV-1 BAC DNAs. Transient transfection of cells with BAC
DNAs was performed with Lipofectamine 2000 (Invitrogen). Vero cells
(pYEbac⌬UL11) and Fd20-1 cells (pYEbac⌬UL11⌬UL20) were grown to
95% confluence in six-well plates. Cells were transfected with BAC DNA
mixed with Lipofectamine 2000 in Opti-MEM medium as recommended by
the manufacturer (Invitrogen). After 6 h of incubation at 37°C, the medium
was removed from the transfected cells, the cells were washed with phosphate-buffered saline, and fresh Dulbecco’s modified Eagle’s medium with
10% fetal calf serum was added. At 72 h posttransfection, virus stocks were
collected.
One-step growth kinetics of YEbac102 mutants. Analysis of one-step growth
kinetics was as described previously (12, 16). Briefly, each virus at a multiplicity of infection (MOI) of 2 was adsorbed to approximately 6 ⫻ 105 Vero
cells at 4°C for 1 h. Thereafter, warm medium was added, and virus was
allowed to penetrate for 2 h at 37°C. Any remaining extracellular virus was
inactivated by low-pH treatment (0.1 M glycine, pH 3.0). Cells and supernatants were harvested immediately thereafter (0 h) or after 4, 8, 12, 18, 24, or
36 h of incubation at 37°C. Virus titers were determined by end point titration
of virus stocks on Vero cells for pYEbac⌬UL11 or on G5 cells for
pYEbac102⌬UL11⌬UL20.
Electron microscopy. Cell monolayers were infected with the indicated virus
at an MOI of 3. All cells were prepared for transmission electron microscopy
examination 24 h postinfection (hpi). Infected cells were fixed in a mixture of
2% paraformaldehyde and 1.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer, pH 7.3. Following treatment with 1% OsO4 and dehydration in an
ethanol series, the samples were embedded in Epon-Araldyte resin and polymerized at 70°C. Thin sections were made on an MTXL ultratome (RMC
Products), stained with 5% uranyl acetate and citrate-nitrate-acetate lead,
and observed with a Zeiss 10 transmission electron microscope as described
previously (14, 30).
Confocal microscopy. To determine intracellular localization of UL20 and
gK in the presence or absence of UL11, Vero cells were grown on coverslips
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TABLE 1. Oligonucleotide primers used for GET recombination
Primer
designation

A

3⬘ UL11-Kan

B

5⬘ UL11-Kan

C

3⬘ UL20-GFPZeo

D

5⬘ UL20 GFPZeo

a
b
c
d

Purpose (product size, bp)

5⬘-GGGTTTTTTAAAAACGACACGCGTGCGACCGTATACAG
AAATTGTTTTGGcggttgatgagagctttgttgtaggtggac-3⬘
5⬘-AACGTCCTCATCACCGACGACGGGGAGGTCGTCTCGCT
GACCGCCCACGACTagccacgttgtgtctcaaaatctctgatgtta-3⬘

UL11 GET recombination
(1,208)

5⬘-CACGGACATCCCCCAAAACACGGGCGCCGACAACGGCA
GACGATCCCTCTTGATGTTagacatgataagatacattgatgagtttgg-3⬘
5⬘-CTGACGTAAGCGACCCTTTGCGGTTTCGGTCTCCCCACC
TCCACCGCACACCCCgtccgttacataacttacggtaaatgg-3⬘

UL20 GET recombination
(2,025)

3⬘ UL11-Rev
5⬘UL11-For

5⬘-GCACCAGCGCGGAGGAGGGC-3⬘
5⬘-ATTGTACGCCCAAGATACAACACCG-3⬘

Diagnostic PCR for wild-type
UL11 (794) or ⌬UL11-Kan
(1,701)

3⬘ UL20-Rev
5⬘ UL20-For

5⬘-ACGGCCTTATCAAAACACTCGCCTC-3⬘
5⬘-GAAGGCTGCGGCCTCGTTCCAG-3⬘

Diagnostic PCR for wild-type
UL20 (909) or ⌬UL20GFPZeo (2,469)

HSV-1-homologous regions are denoted by uppercase letters; lowercase letters signify sequences which bind to the marker gene.

in six-well plates to 95% confluence and then transfected with UL11, UL11
and UL20, UL11 and gK, or UL11, UL20, and gK by using Lipofectamine
2000 (Invitrogen) as recommended by the manufacturer. After 6 h of incubation at 37°C, the medium was removed from the transfected cells, cells were
washed with phosphate-buffered saline, and fresh Dulbecco’s modified
Eagle’s medium with 10% fetal calf serum was added. At 48 h posttransfection
cells were washed with Tris-buffered saline (TBS), fixed with electron microscopy
grade 3% paraformaldehyde (Electron Microscopy Sciences, Fort Washington,
PA) for 15 min, washed twice with PBS–50 mM glycine, and permeabilized with
1.0% Triton X-100. Monolayers were subsequently blocked for 1 h with 7%
normal goat serum and 7% bovine serum albumin in TBS (TBS blocking buffer)
before incubation for 2 h with either anti-GFP (Immunology Consultants Laboratory, Newberg, OR) for detection of UL11, anti-FLAG (Sigma Chemical) for
detection of UL20, anti-V5 (Invitrogen, Carlsbad, CA) for detection of gK,
anti-TGN 46 (Serotec, Raleigh, NC) for detection of the trans-Golgi network, or
a combination of these antibodies as indicated. Alternatively, to determine the
intracellular localization of UL11 and UL20 during an active virus infection, 143
TK⫺ cells were prepared as described above with the exception that 24 h posttransfection the cells were infected with YEbac102⌬UL11⌬UL20 at an MOI of
2. At 48 h postinfection, the cells were prepared as described above.
To visualize specific fluorescence, secondary antibodies were added to the
cells. Briefly, cells were washed thoroughly and Alexafluor 488, Alexafluor 594,
and Alexafluor 647 at a 1:750 dilution were added and incubated for 1 h. Cells
were washed again and mounted on slides. The fluorescence was then visualized
using a Leica TCS SP2 laser-scanning confocal microscope (Leica Microsystems,
Exton, PA) fitted with a CS APO 63⫻ Leica objective (numerical aperture, 1.4).
Individual optical sections in the z axis, averaged six times, were collected at the
zoom indicated in the figure legends in series in the different channels at a
resolution of 1,024 ⫻ 1,024 pixels as described previously (14–17). Images were
compiled and rendered in Adobe Photoshop.

RESULTS
Construction of the HSV-1 BACs pYEbac102⌬UL11 and
pYEbac102⌬UL11⌬UL20. The complete HSV-1(F) genome
has been cloned into a BAC (pYEbac102), enabling the genetic manipulation of the HSV-1 genome in E. coli (41). Previously, we utilized the BAC-based GET homologous recombination system to construct deletions within the gB, UL20,
and gK genes in E. coli (31). A similar strategy was utilized to
construct an HSV-1 BAC with most of the UL11 ORF deleted.
Deletion of the UL11 gene was accomplished using specific
oligonucleotide primers (Table 1). Specifically, the UL11 deletion encompassed 194 bp of the UL11 ORF, while 97 bp of

the 5⬘ UL11 ORF remained intact. This deletion was engineered to ensure that the UL12 ORF, which overlaps with the
UL11 ORF by 86 bp, was unaffected (see Materials Methods).
A similar deletion of the UL11 gene was constructed in the
pYEbac102⌬UL20 genetic background.
For construction of the ⌬UL11-Kan mutation, primers A
and B were used for homologous recombination and positioned to remove a 198-bp region of the UL11 gene upon
insertion of the kanamycin cassette extending from nucleotide
96 of UL11 to 3 bases past the UL11 stop codon (Table 1; Fig.
1). The UL11 deletion was constructed so that it does not
disrupt the UL12 ORF, which overlaps the 5⬘ end of UL11 by
87 bases (see Materials and Methods). An identical UL11
insertion-deletion was constructed on both the wild-type
pYEbac102 genetic background and the pYEbac102⌬UL20
genetic background. A similar methodology was previously
used to construct a recombinant virus carrying a deletion of the
UL20 gene after insertion of a GFP-zeocin gene cassette
(⌬UL20-GFPZeo) (14). This construction deleted a 353-bp
region of the UL20 gene extending from the UL20 ATG to the
HpaI site located within the UL20 ORF (Table 1; Fig. 1). Each
pYEbac102 mutant construct contains one or more of the
insertion-deletion mutations mentioned above: pYEbac102⌬UL11
contains the ⌬UL11-Kan mutation, pYEbac⌬UL20 contains
the ⌬UL20-GFPZeo mutation, and pYEbac102⌬UL11⌬UL20
contains both the ⌬UL11-Kan and the ⌬UL20-GFPZeo mutations (Fig. 1).
PCR-based confirmation of the pYEbac102⌬UL11 and
pYEbac102⌬UL11⌬UL20 genotypes. The YEbac102-based genomic
constructs were tested for the presence of the engineered insertion-deletion mutations via diagnostic PCR. Primers a and b
(Table 1; Fig. 1), located outside and bracketing the UL11
gene, amplified the predicted 794-bp UL11 DNA fragments
from pYEbac102 and pYEbac102⌬UL20 (Fig. 2, lanes 2 and
3). Primers c and d (Table 1; Fig. 1), located outside and
bracketing the UL20 gene, amplified the predicted 909-bp
UL20 DNA fragments from pYEbac102 and pYEbac102⌬UL11
(Fig. 2, lanes 7 and 9). In contrast, diagnostic PCR against the
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pYEbac102⌬UL11 and pYEbac102⌬UL11⌬UL20 DNAs using primers a and b (Table 1; Fig. 1) produced a PCR-amplified DNA fragment of 1,608 bp, as predicted due to the insertion of the kanamycin gene cassette (Fig. 2, lanes 4 and
5). Primers c and d (Table 1; Fig. 1), located outside and
bracketing the UL20 gene, amplified the predicted 2,469bp DNA fragment from pYEbac102⌬UL20 and pYEbac

102⌬UL11⌬UL20 due to the insertion of the GFP-zeocin gene
cassette (Fig. 2, lanes 8 and 10).
Production of infectious virus from pYEbac102-based constructs. To generate virus stocks from the mutant pYEbac102
constructs, transient transfection of individual BAC DNAs was
performed into Vero cells or the Fd20-1 cell line, which is
transformed with the UL20 gene and was shown to efficiently

FIG. 2. PCR-based diagnostic analysis of pYEbac102⌬UL11 and pYEbac102⌬UL20 mutants. Oligonucleotide primers a and b (Table 1) were
utilized to amplify DNA fragments containing the inserted Kan gene cassette. (i) Amplification with primers a and b produced the predicted
1,701-bp DNA fragment for the pYEbac102⌬UL11 and pYEbac102⌬UL11⌬UL20 genomes, consistent with the insertion of the Kan gene cassette,
and the predicted 794-bp fragment for the pYEbac102 and pYEbac102⌬UL20 controls. (ii) Amplification with primers c and d (Table 1) produced
the predicted 2,469-bp DNA fragment for the pYEbac102⌬UL20 and pYEbac102⌬UL11⌬UL20, consistent with insertion of the GZ gene cassette,
and the 999-bp predicted DNA fragment for the pYEbac102 and pYEbac102⌬UL11⌬UL20 controls.
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FIG. 1. Schematic of the strategy for the construction of pYEbac102 mutant BACs. (A) The top line represents the prototypic arrangement
of the HSV-1 genome, with the unique long (UL) and unique short (US) regions flanked by the terminal repeat (TR) and internal repeat (IR)
regions. (B) Shown are the expanded genomic regions of the UL11 and UL20 ORFs, the approximate locations of the genomic sites to which
insertion of the marker genes was targeted, and the primers used in diagnostic PCR to confirm the presence of each mutation. (C) PCR fragments
containing the kanamycin resistance or GFP-zeocin resistance gene cassette flanked by approximately 50 bp of viral sequences on both sides were
used for targeted GET recombination in E. coli to construct pYEbac102 mutant BACs with insertion-deletion mutations in the UL11 and/or UL20
ORFs, respectively. The approximate locations of the primers used in amplification of each PCR fragment are also shown. CMV, cytomegalovirus.
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complement UL20-null viruses (30). Specifically, pYEbac102
and pYEbac102⌬UL11 were transfected into Vero cells, while
pYEbac102⌬UL20 and pYEbac102⌬UL11⌬UL20 were transfected into the UL20-complementing Fd20-1 cells (30). For all
transfection experiments, virus plaques became visible at 72 h
posttransfection, and virus stocks were collected at appropriate
points when exhibiting maximum cytopathic effects.
Plaque morphology and replication kinetics of HSV-1
YEbac102 mutants. As we have noted previously (31), construction of mutant HSV-1 viruses using the YEbac102 plasmid allows for the rapid generation of recombinant viruses
carrying desired mutations without the need for extensive
plaque purification, which is normally needed when recombinant viruses are produced via classical homologous recombination in cell culture. To assess and compare the effects of the
deletion of the UL11 and UL20 genes in the context of
the same viral HSV-1(F) genome on cell-to-cell spread, the
plaque morphologies of the YEbac102, YEbac102⌬UL11,
YEbac⌬UL20, and YEbac102⌬UL11⌬UL20 viruses were examined in Vero cells in the presence or absence of complementation by either the UL11 or UL20 protein provided in
trans via transient expression (Fig. 3). Complementation experiments were performed by transfection of expression plasmids for UL20, UL11, or both UL20 and UL11 followed by
infection with either the ⌬UL20, ⌬UL11, or ⌬UL11⌬UL20
virus at 24 h posttransfection. As expected, the wild-type
YEbac102 produced large plaques on all infected cells (Fig.
3A and B). Infection of noncomplementing cells with either
YEbac102⌬UL20 or YEbac102⌬UL20⌬UL11 resulted in very
small plaques containing on average one or two cells (Fig. 3E

and G), while infection of noncomplementing cells with the
pYEbac102⌬UL11 virus resulted in plaques which were approximately one-third the average size of those of the wild-type
virus (Fig. 3C). Complementation of YEbac102⌬UL11,
YEbac102⌬UL20, or YEbac102⌬UL11/UL20 by UL11, UL20,

FIG. 4. Viral replication kinetics. A comparison of the viral replication characteristics of YEbac102 (F), YEbac102⌬UL20 (■),
YEbac102⌬UL11 (Œ), and YEbac102⌬UL11⌬UL20 (E) on Vero cells
is shown. One-step growth kinetics of infections virus production were
calculated after infection at an MOI of 2 followed by incubation at
37°C. Error bars indicate standard deviations.
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FIG. 3. Plaque phenotypes of UL11-null, UL20-null, and UL11/UL20 double-null viruses under complementing and noncomplementing
conditions. Vero cell monolayers were either mock transfected or transfected with plasmids expressing UL11, UL20, or both UL11 and UL20.
Transfected cells were infected at 24 h posttransfection with the corresponding viruses, pYEbac102, pYEbac102⌬UL11, pYEbac102⌬UL20, and
pYEbac102⌬UL11⌬UL20. Individual viral plaques were visualized at 24 h postinfection by immunohistochemistry.
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FIG. 5. Ultrastructural morphologies of the YEbac102⌬UL11 (a), YEbac102⌬UL20 (b), and YEbac102⌬UL11⌬UL20 (c) viruses. Confluent
cell monolayers were infected with the indicated virus at an MOI of 2, incubated for 24 h at 37°C, and prepared for transmission electron
microscopy. Panels A, low magnification of an infected cell; panels B and C, higher magnifications of the cells shown in panels A. Nuclear (N),
cytoplasmic (C), and extracellular (E) spaces are marked; bars show the relative magnification scale.

or UL20 plus UL11, respectively, produced viral plaques
similar in size to those of the parental wild-type virus
(Fig. 3D, F, and H). Furthermore, complementation of
YEbac⌬UL20⌬UL11 with the UL20 alone produced a viral
plaque similar in size to that of the YEbac⌬UL11 virus (not
shown). Complementation of the mutant viruses to wild-type
plaque phenotypes was observed at a rate of 60 to 70% for all
mutant viruses, indicating the absence of any secondary mutations that could account for the observed mutant phenotypes.
To examine the effects of the various mutations on virus
replication, Vero cells were infected at an MOI of 2 with either
the wild-type or each mutant virus. Virus stocks were prepared
at 0, 4, 8, 12, 18, 24, and 36 hpi and titrated in triplicate
onto complementing cells (Fig. 4). The kinetics of both
YEbac102⌬UL20 and YEbac102⌬UL11⌬UL20 were similar
to each other and substantially slower than that of the YEbac102
virus, with maximum titers reduced more than 3 logs in comparison to the YEbac102 at 36 hpi. The replication kinetics of
the YEbac102⌬UL11 virus was reduced in comparison to that

of YEbac102, with maximum titers reduced by more than 1 log
at 36 hpi.
Ultrastructural characterization of the YEbac102⌬UL11
and YEbac102⌬UL11⌬UL20 mutant viruses. The ultrastructural phenotypes of the YEbac102⌬UL20, YEbac102⌬UL11,
and YEbac102⌬UL11⌬UL20 viruses relative to the YEbac102
parental virus were investigated utilizing transmission electron
microscopy at 24 hpi. As expected, the YEbac102 virus exhibited no apparent defects in virion egress, as exemplified by the
presence of fully enveloped virions extracellularly as well as the
presence of fully enveloped virions intracellularly (31) (not
shown). Unlike the case for the wild-type virus, ultrastructural
visualization of YEbac102⌬UL11-, YEbac102⌬UL20-, and
YEbac102⌬UL11⌬UL20-infected Vero cells revealed cytoplasmic defects in virion envelopment. The YEbac102⌬UL11
mutant produced largely unenveloped capsids in the cytoplasm
embedded within morphologically darker-stained areas that
may be caused by the accumulation of tegument proteins
(Fig. 5a). This ultrastructural phenotype appeared to be
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FIG. 5—Continued.
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FIG. 6. Digital images of confocal micrographs showing UL11 localization. Vero cell monolayers were transfected with the UL11-GFPexpressing plasmid. At 24 h posttransfection, cells were washed thoroughly, fixed, and stained with the anti-GFP antibody (A1) or with the Golgi
specific marker TGN46 (A2) and fluorescence was visualized by confocal microscopy. A3, overlay. Magnification, ⫻63; zoom, ⫻2.

DISCUSSION
HSV-1 cytoplasmic virion envelopment is thought to be mediated by complex interactions among tegument proteins and
viral glycoproteins embedded in the TGN membranes. A number of viral glycoproteins have been shown to either interact
with tegument proteins or otherwise affect cytoplasmic envelopment. In this study, we examined potential physical and
functional relationships between the UL11 protein and the
gK/UL20 heterodimer in cytoplasmic virion envelopment. Specifically, it was of interest to compare the ultrastructural phenotype of a newly constructed UL11-null virus in the HSV-1(F)
background with those of the gK-null and UL20-null viruses
and to determine whether UL11 and the gK/UL20 heterodimer functioned in a dependent manner or independently
of each other. The salient features of our results are as follows:
(i) the HSV-1 UL11 protein functioned exclusively in cytoplasmic envelopment as evidenced by the accumulation of cytoplasmic capsids in cells infected with the HSV-1(F) UL11-null
virus in a manner similar to the previously described PRV
UL11-null virus (24); (ii) the UL20-null and UL11-null plaque
morphologies, as well as their ultrastructural phenotypes, were
substantially different; (iii) a UL20/UL11 double-null virus
produced plaques and ultrastructural morphologies closely resembling those of the UL20-null viral phenotype; (iv) the
UL11/UL20 double-null virus replicated with replication kinetics similar to that of the UL20-null virus; and (v) UL11 and
UL20 were transported independently of each other in transient-transfection experiments. These results led to the conclusion that UL20 and UL11 transport and localize at the TGN
independently of each other; however UL20 must function at a
virion morphogenetic step occurring prior to and required for
UL11 function.
Recently, we constructed and characterized deletion mutations of the gK, UL20, and gB genes by utilizing the HSV-1(F)
genome cloned into a BAC system (31). The HSV-1 gK-null
and UL20-null viruses produced smaller plaques than the original gK-null and UL20-null viruses, which were constructed via
classical recombination/deletion methodologies in the HSV1(KOS) genetic background (14, 22). This apparent very-smallplaque phenotype could be due to the difference in viral
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dissimilar to that of a previously constructed HSV-1(F) null
virus (2) inasmuch as there was no noticeable accumulation
of capsids within nuclei of infected cells. In contrast, the
YEbac102⌬UL11 ultrastructural morphology was similar to
that produced by a recombinant PRV that lacked the UL11homologous gene, although the tegument-like staining material surrounding the unenveloped capsids did not appear
to be as concentrated as in the PRV case (24). As reported
previously (31), the YEbac102⌬UL20 mutant virus produced unenveloped capsids in the cytoplasm, as well as
aberrantly enveloped virions (Fig. 5b). Ultrastructural examination of Vero cells infected with the YEbac102⌬UL11⌬UL20 double-null virus revealed virion morphogenetic defects that were quite similar to those of the UL20null virus and different from those of the UL11-null virus
(Fig. 5c).
UL11 and UL20 are independently transported to the TGN.
It has been previously reported that UL11 localizes to the
TGN (25). In agreement with these findings, transient expression of UL11 in Vero cells resulted in localization of the UL11
protein in the TGN (Fig. 6).
Previously, we showed that gK or UL20 alone remained at
the rough endoplasmic reticulum when expressed alone. However, coexpression of gK and UL20 resulted in the TGN localization of both proteins, strongly suggesting that these two
proteins interact and that this interaction is necessary for the
coordinate transport to the TGN (14). To determine whether
either UL20 or gK expression was able to alter the TGN
localization of the UL11 protein, the UL11 gene was transiently expressed in Vero cells concurrently with either the
UL20 or gK gene alone or with both the gK and UL20 genes.
UL11 localized to the TGN in the presence of either UL20,
gK, or both UL20 and gK (Fig. 7). Additional experimentation
was performed to ascertain whether the presence or absence of
the UL20 or gK gene could affect the TGN localization of the
UL11 protein in the context of other viral proteins. In these
experiments, 143 TK⫺ cells were transfected with either the
UL11, UL20, or both UL11 and UL20, and 24 h posttransfection, cells were infected with the YEbac102⌬UL11⌬UL20 virus. Again, the UL11 protein localized efficiently to the TGN
(Fig. 8).
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FIG. 7. Comparison of UL11 intracellular localization in the presence or absence of gK/UL20. Vero cells were transfected with a combination
of plasmids expressing UL11-GFP, UL20, and/or gK. At 24 h posttransfection, cells were washed thoroughly, fixed, and prepared for confocal
microscopy after staining with the appropriate antibodies under the appropriate conditions. UL11 was stained with the anti-GFP antibody, UL20
with the anti-FLAG antibody, and gK with the anti-V5 antibody. Magnification, ⫻63; zoom ⫻2.

strains. Alternatively, we favor the hypothesis that the BACassisted construction of mutant viruses allowed the rapid generation of mutant genomes in E. coli, substantially lowering the
possibility that compensatory mutations that increase plaque
size may be selected after serial passage of the KOS gK- or
UL20-null viruses. Appreciably, the very-small-plaque phenotype of the UL20/gK-null viruses exemplify that the gK/UL20
proteins are essential for virus spread.
To compare the role of UL11 in virion morphogenesis, the
YEbac102⌬UL11 (⌬UL11) virus was produced using our previously described BAC-assisted mutagenesis procedure (27,
31). The ⌬UL11 virus was constructed by deleting most of the

UL11 ORF, taking care not to interrupt the UL12 ORF, which
overlaps with the UL11 ORF by 87 bp. Previously, a similar
UL11-null virus, R7219, carrying a UL11 deletion of 176 bp
was constructed using classical recombination experiments (2).
In comparison, the ⌬UL11 virus carried an additional deletion
of 18 bp. Overall, the new ⌬UL11virus confirmed previous
findings with the R7219 virus, since both viruses exhibited a
significant reduction in virus replication. However, the R7219
virus exhibited a major defect in capsid envelopment via budding through the nuclear membrane, resulting in an unusual
accumulation of intranuclear capsids as well as a reduced number of enveloped capsids in the cytoplasm (2). In contrast to
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FIG. 8. Intracellular localization of the UL11 and UL20 proteins in virus-infected cells. Vero cells were transfected with plasmids expressing
UL11-GFP, UL20, or both. At 24 h posttransfection, cells were infected at an MOI of 2 with YEbac102⌬UL11⌬UL20. At 24 h postinfection, cells
were washed thoroughly, fixed, stained with appropriate antibodies, and prepared for confocal microscopy. Magnification, ⫻63; zoom ⫻2.

these findings, the ⌬UL11virus accumulated capsids in the
cytoplasm of infected cells that failed to acquire cytoplasmic
envelopes. There was no apparent defect in nuclear egress as
evidenced by the lack of accumulation of capsids in the nucleus
or incomplete nuclear budding processes. Importantly, the
⌬UL11 virus accumulated capsids in the cytoplasm of infected
cells in large aggregates surrounded by electron-dense material, which may be derived by tegument proteins. A similar
ultrastructural phenotype was observed for the PRV UL11null virus, with the exception that capsid aggregates were embedded within strongly electron-dense structures of uniform
density attributed to the accumulation of capsid proteins (24).
Therefore, the HSV-1(F) UL11 gene functions in cytoplasmic
envelopment in a manner similar to that of the PRV UL11
gene.
The UL11 protein is anchored to TGN membranes through
an N-terminal myristylate anchor. In addition, the UL11 protein contains a dileucine and an acidic amino acid motif, which
are known to be involved in physical interactions with the
UL16 protein, as well as in recycling from the plasma membranes to the TGN. Deletion of either motif abrogates UL16
interaction and plasma membrane TGN recycling (25, 26). The
⌬UL11 virus is predicted to code for the first 32 amino acids of
the UL11 protein, effectively retaining the dileucine motif

while deleting the entire acidic motif. In contrast, the R7219
virus is predicted to code for the first 39 amino acids of the
UL11 protein, effectively retaining the dileucine motif as well
as three of the seven amino acids of the acidic acid motif. Thus,
it can be predicted that both UL11 peptides encoded by the
⌬UL11 and R7219 viruses could be myristylated and anchored
to TGN membranes. However, the ⌬UL11 protein could not
interact with the UL16 protein, since the entire acidic motif is
deleted. In contrast, it is possible that the R7219 UL11 protein
may be able to interact with the UL16 protein, since the
dileucine motif is intact and three of the seven acidic amino
acids remain with the protein. It has been reported that the
UL16 tegument protein is present on intranuclear assemblons
and a structural component of mature virions (35). Therefore,
these subtle differences in the UL11 amino-terminal peptides
may account for the reported delay of nuclear egress for the
R7219 virus, which may be caused by an aberrant interaction of
the UL11 amino-terminal peptide encoded by the R7219 virus
with UL16 at the nuclear membrane.
The ⌬UL11 ultrastructural phenotype is similar to that of
the PRV UL11-null virus, with the exception that the PRV
UL11-null virus formed capsids within a highly uniform electron-dense material, which appeared to be derived from tegument proteins. In contrast, the ⌬UL11 mutant appeared to
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have a diffuse electron-dense material surrounding the unenveloped capsids. The 32-amino-acid UL11 peptide encoded by
the UL11-null virus retains the site of myristylation at its N
terminus and thus could be anchored to the TGN membranes.
The PRV UL11-null virus does not code for any UL11-derived
peptide, since the UL11 initiation codon was altered by sitedirected mutagenesis (24). Therefore, the ⌬UL11 amino-terminal peptide within TGN membranes as well as in the cytoplasm may interact with other tegument proteins, preventing
the more pronounced aggregation of tegument proteins produced by the PRV UL11-null virus.
To address potential synergistic effects between the UL11
and UL20 genes in cytoplasmic envelopment, we constructed
the ⌬UL20/UL11 double-null virus. Surprisingly, the ⌬UL20/
UL11 double-null virus exhibited replication characteristics
very similar to those of the UL20-null virus. Similarly, the
ultrastructural phenotype of the double-null virus was largely
similar to that of the UL20-null virus, without any apparent
contribution by the UL11 null mutation. Additional studies
with transient-expression systems revealed that UL11 and
UL20/gK were transported to the TGN independently of each
other, indicating that they did not physically or otherwise functionally interact either in cells expressing only the UL11 and
UL20/gK genes or in cells infected with virus. Taken together,
these results suggest that the UL11 functions in cytoplasmic
envelopment are totally dependent on UL20 expression. One
way to interpret this apparent dependence of UL11 on UL20 is
that the UL20 protein functions in an earlier cytoplasmic envelopment step with UL11, which is required for UL11 function. However, this prediction is contrary to the observation
that the UL11-null virions accumulate capsids with aberrant
tegument-derived structures, apparently distal to TGN membranes. One interpretation of these results is that in the absence of UL20 protein there is an irreversible attachment to
TGN membranes that cannot be overcome by the UL11 null
mutation. In contrast, the UL11 null mutation may allow initial
binding of tegumented capsids to membranes followed by capsid release, forming the observed aggregates of capsids embedded in tegument-like material. In this instance, the known
physical interaction of UL11 with UL16 may in part be responsible for the observed defect in tegument protein accumulation
in the cytoplasm, since in the absence of UL11, UL16 as well
as other tegument proteins that may interact with UL11 would
not bind to TGN membranes but would remain free in the
cytoplasm. An alternative scenario is based on the observation
that the cellular intracytoplasmic membranes seemed to be
restructured in the absence of the PRV UL11, indicating that
UL11 may play some stabilization role in Golgi-TGN membranes in infected cells (24). In this regard, it is possible that
gK/UL20 may play a similar stabilization role for TGN membranes and specifically at capsid budding sites. In Vero cells
Golgi stacks are largely fragmented during infection (8), which
would argue against overall Golgi-TGN stabilization roles for
either gK or UL20. However, concurrent action of gK/UL20
and UL11 at TGN budding sites may occur, with gK/UL20
playing a dominant role over UL11.
The UL20/gK heterodimer is of paramount importance in
cytoplasmic envelopment, since deletion of either gene causes
profound accumulation of cytoplasmic capsids and reduction
of viral titers by more than 3 logs, while viral plaques are
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greatly diminished in size. It is important to determine if the
UL20/gK functions precedes those of other viral glycoproteins
that are known to function in cytoplasmic virion envelopment,
such as gE/gI and gM. In this regard, an investigation of the
phenotypes of double mutants carrying deletions in more than
one gene may shed some light on the sequence of events that
control cytoplasmic envelopment.
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